Ahead-of-print

  • HOME
  • BROWSE ARTICLES
  • Ahead-of-print

Articles in E-pub version are posted online ahead of regular printed publication.

Correspondence
Correspondence to editorial “Metabolic health in antiviral era of chronic hepatitis B”
Rui Huang, Mindie H. Nguyen
Received April 29, 2025  Accepted May 4, 2025  
View: 68   Download: 1
Research Letter
Contemporary Burden of Mortality from Chronic Liver Disease by Sex and Race/Ethnicity in the United States
Donghee Kim, Pojsakorn Danpanichkul, Karn Wijarnpreecha, George Cholankeril, Aijaz Ahmed
Received April 10, 2025  Accepted May 3, 2025  
View: 65   Download: 8
Correspondence
Correspondence to editorial “Type 2 diabetes as a key metabolic risk factor for adverse outcomes in nucleos(t)ide analogue-treated chronic hepatitis B”
Rui Huang, Mindie H. Nguyen
Received April 29, 2025  Accepted May 3, 2025  
View: 67   Download: 0
Correspondence to letter to the editor on “Risk Stratification of Metabolic Dysfunction-Associated Steatotic Liver Disease: The KASL Pathway
Hye Won Lee, Seung Up Kim
Received April 29, 2025  Accepted May 3, 2025  
View: 67   Download: 2
Research Letter
Non-infectivity of Hepatitis B Virus Under Nucleoside Analog Therapy Revealed Through Auxiliary Partial Orthotopic Liver Transplantation (APOLT)
Xiaojie Chen, Guiwen Guan, Lin Wei, Jidong Jia, Xiangmei Chen, Fengmin Lu, Zhijun Zhu
Received April 9, 2025  Accepted May 1, 2025  
View: 57   Download: 7
Letter to the Editor
Molecular Stratification of Hepatocellular Carcinoma by Metabolic-Signaling Pathways Guides Precision Immunotherapy and TACE Therapy
Binghua Li, Yanchao Xu, Yican Zhu, Yukun Zhang, Zijie Wu, Tianci Luo, Laizhu Zhang, Weiwei Hu, Decai Yu
Received March 27, 2025  Accepted April 29, 2025  
View: 74   Download: 7
Editorial
Type 2 diabetes as a key metabolic risk factor for adverse outcomes in nucleos(t)ide analogue-treated chronic hepatitis B
Heejoon Jang, Won Kim
Received April 16, 2025  Accepted April 25, 2025  
View: 129   Download: 11
Unveiling TRIB3: A New Mediator in MET-Driven Hepatocellular Carcinoma Progression
Many Sze Man CHAN, Terence Kin Wah LEE
Received April 23, 2025  Accepted April 24, 2025  
View: 149   Download: 15
Correspondence
Correspondence to editorial on “Molecular Classification of Hepatocellular Carcinoma based on Zoned Metabolic Feature and Oncogenic Signaling Pathway.”
Tomoko Aoki, Naoshi Nishida, Masatoshi Kudo
Received April 18, 2025  Accepted April 24, 2025  
View: 109   Download: 8
Editorial
RISK STRATIFICATION OF METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE: THE KASL PATHWAY
May Xuan GOH, Xin En GOH, Jarell Jie-Rae TAN, Vincent L CHEN, Yu Jun WONG
Received April 14, 2025  Accepted April 24, 2025  
View: 118   Download: 8
Reply to Correspondence
GULP1: New Hope for Hepatocellular Carcinoma: Reply to Correspondence on “GULP1 as a Novel Biomarker in HCC”
Yuhao Xie, Lu-Qi Cao, John Wurpel, Zhe-Sheng Chen
Received April 14, 2025  Accepted April 24, 2025  
View: 132   Download: 5
Correspondence
Correspondence to editorial “Targeting CD36 to reinvigorate CD8+ T Cells in early-stage hepatocellular carcinoma”
Yifei Qin, Peng Lin, Huijie Bian, Zhi-Nan Chen, Jiao Wu
Received April 11, 2025  Accepted April 24, 2025  
View: 185   Download: 13
Letter to the Editor
Letter “Radiogenomics of intrahepatic cholangiocarcinoma predicts immunochemotherapy response and identifies therapeutic target”
Yuqian Liu, Ruiyun Guo, Jun Ma
Received April 6, 2025  Accepted April 21, 2025  
View: 184   Download: 18
Original Article
GLP-1 RA and Reduced Liver and Non-Liver Complications in Adults with T2D and MASLD: A Target Trial Emulation Study
Xianhua Mao, Xinrong Zhang, Rongtao Lai, Ka-Shing Cheung, Man-Fung Yuen, Ramsey Cheung, Wai-Kay Seto, Mindie H Nguyen
Received December 5, 2024  Accepted April 21, 2025  
View: 485   Download: 53
HTD1801 Demonstrates Promising Potential for Histologic Improvements in MASH in Both a Preclinical and Phase 2 Study
Vincent Wai-Sun Wong, Guy W. Neff, Adrian M. Di Bisceglie, Ru Bai, Junwei Cheng, Meng Yu, Alexander Liberman, Liping Liu, Nadege Gunn
Received February 8, 2025  Accepted April 17, 2025  
View: 345   Download: 24
Reply to Correspondence
Reply to authors’ reply: “Baveno VI-SSM stratifies the risk of portal hypertension-related events in patients with HBV-related cirrhosis”
Mathias Jachs, Mattias Mandorfer
Received April 9, 2025  Accepted April 14, 2025  
View: 174   Download: 4
Review
Role of amino acids in the regulation of hepatic gluconeogenesis and lipogenesis in metabolic dysfunction-associated steatotic liver disease
Eiji Kakazu, Masaaki Mino, Tatsuya Kanto
Received January 14, 2025  Accepted April 12, 2025  
View: 590   Download: 91
Correspondence
Correspondence to Editorial on “Switching to Besifovir in Patients with Chronic Hepatitis B Receiving Tenofovir Disoproxil Fumarate: A Randomized Trial”
Hyung Joon Yim, Seong Hee Kang, Young Kul Jung, Jin Mo Yang
Received April 7, 2025  Accepted April 8, 2025  
View: 152   Download: 8
Original Article
Sex Disparities in Alcohol-Associated Liver Disease and Subtype Differences in Alcohol-attributable Cancers in the United States
Pojsakorn Danpanichkul, Yanfang Pang, Tanuj Mahendru, Primrose Tothanarungroj, Luis Antonio Díaz, Juan Pablo Arab, Pimtawan Jatupornpakdee, Mark D. Muthiah, Kwanjit Duangsonk, Won-Mook Choi, Daniel Q. Huang, Donghee Kim, Mazen Noureddin, Karn Wijarnpreecha, Suthat Liangpunsakul, Amit G. Singal, Ju Dong Yang
Received February 12, 2025  Accepted April 8, 2025  
View: 815   Download: 50
MET promotes hepatocellular carcinoma development through the promotion of TRIB3-mediated FOXO1 degradation
Tiantian Wang, Dean Rao, Chenan Fu, Zhoubin Sun, Yiming Luo, Junli Lu, Jie Jin, Han Li, Feimu Fan, Huifang Liang, Wenjie Huang, Limin Xia
Received December 24, 2024  Accepted April 8, 2025  
View: 732   Download: 97
Editorial
Metabolic Health in Antiviral Era of Chronic Hepatitis B
Shang-Chin Huang, Jia-Horng Kao
Received April 3, 2025  Accepted April 8, 2025  
View: 192   Download: 16
Correspondence
Revisiting unmet needs in clinical research on direct-acting antiviral therapy for HCC patients
Teng-Yu Lee, Pei-Chien Tsai, Shou-Wu Lee, Ming- Lung Yu
Received April 2, 2025  Accepted April 2, 2025  
View: 320   Download: 12
Original Article
Risk stratification by noninvasive tests in patients with metabolic dysfunction-associated steatotic liver disease
Hye Won Lee, Jae Seung Lee, Mi Na Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim
Received December 30, 2024  Accepted April 2, 2025  
View: 423   Download: 53
Correspondence
Correspondence: Response to Editorial on “GULP1, a Multifaceted Biomarker and Therapeutic Target in HCC”
Soon Sun Kim, Hyung Seok Kim, Jae Youn Cheong, Jung Woo Eun
Received March 28, 2025  Accepted April 2, 2025  
View: 213   Download: 6
Research Letter
Lipidomic analysis of alcohol use disorder patients revealed the biomarkers for alcohol-related liver disease susceptibility
Dongyao Wang, Hongwei Zhang, Yuxiao Tang
Received February 26, 2025  Accepted March 30, 2025  
View: 294   Download: 30
Review
Emerging Therapies and Real-World Application of Metabolic Dysfunction-Associated Steatotic Liver Disease Treatment
Hee Yeon Kim, Mary E. Rinella
Received January 22, 2025  Accepted March 30, 2025  
View: 782   Download: 108
Editorial
Targeting CD36 to reinvigorate CD8+ T Cells in early-stage hepatocellular carcinoma
Valerie Chew
Received March 25, 2025  Accepted March 28, 2025  
View: 378   Download: 31
Correspondence
Correspondence to editorial 3 on “Baveno VI-SSM stratifies the risk of portal hypertension-related events in patients with HBV-related cirrhosis”
Haiyu Wang, Jinjun Chen
Received March 23, 2025  Accepted March 28, 2025  
View: 217   Download: 4
Correspondence to editorial 2 on “Baveno VI-SSM stratifies the risk of portal hypertension-related events in patients with HBV-related cirrhosis”
Haiyu Wang, Jinjun Chen
Received March 23, 2025  Accepted March 28, 2025  
View: 217   Download: 3
Correspondence to editorial 1 on “Baveno VI-SSM stratifies the risk of portal hypertension-related events in patients with HBV-related cirrhosis”
Haiyu Wang, Jinjun Chen
Received March 23, 2025  Accepted March 28, 2025  
View: 244   Download: 9
Review
Tracking the trajectory of kidney dysfunction in cirrhosis: the acute kidney injury – chronic kidney disease spectrum
Vishnu Girish, Rakhi Maiwall
Received November 24, 2024  Accepted March 24, 2025  
View: 624   Download: 100
Editorial
GULP1, A Multifaceted Diagnostic Biomarker and Potential Therapeutic Target in Hepatocellular Carcinoma: Editorial on “GULP1 as a Novel Diagnostic and Predictive Biomarker in Hepatocellular Carcinoma”
Yuhao Xie, Lu-Qi Cao, John Wurpel, Zhe-Sheng Chen
Received March 18, 2025  Accepted March 21, 2025  
View: 280   Download: 21
Besifovir: a viable option for long-term disease control in chronic hepatitis B
Wai-Kay Seto
Received March 15, 2025  Accepted March 20, 2025  
View: 192   Download: 11
Refining Portal Hypertension Assessment: The Clinical Significance of Spleen Stiffness Measurement in the Baveno VII Era
Do Seon Song
Received March 13, 2025  Accepted March 20, 2025  
View: 225   Download: 23
Letter to the Editor
Letter “Direct-acting antiviral therapy for patients with HCV-related hepatocellular carcinoma: A nationwide cohort study”
Qiong Wang, Zhongqing Qian, Xiaodi Yang, Deyan Chen, Xiaojing Wang, Fuliang Chen
Received March 13, 2025  Accepted March 19, 2025  
View: 246   Download: 14
Correspondence
Correspondence: Response to the Letter Regarding "GULP1 as a Novel Diagnostic and Predictive Biomarker in Hepatocellular Carcinoma"
Hyung Seok Kim, Soon Sun Kim, Jae Youn Cheong, Jung Woo Eun
Received March 12, 2025  Accepted March 15, 2025  
View: 377   Download: 24
Editorial
Unveiling GULP1 as a Hepatocyte-Specific Role for Recurrence: Editorial on “GULP1 as a Novel Diagnostic and Predictive Biomarker in Hepatocellular Carcinoma”
Pengde Lu, Ning Wang
Received March 11, 2025  Accepted March 15, 2025  
View: 301   Download: 20
A non-invasive risk stratification tool for hepatitis B-related liver cirrhosis: the Baveno VI-SSM combined model.
Ruiling He, Bingtian Dong, Xiaolong Qi
Received March 11, 2025  Accepted March 15, 2025  
View: 337   Download: 26
Predicting decompensation risk in compensated HBV cirrhosis: Eternal sunshine for a spotless mind?
Mathias Jachs, Mattias Mandorfer
Received March 11, 2025  Accepted March 15, 2025  
View: 298   Download: 24
Original Article
Impact of components of metabolic syndrome on long-term outcomes of CHB with nucleos(t)ide analogue treatment
Rui Huang, Dae Won Jun, Hidenori Toyoda, Yao-Chun Hsu, Huy Trinh, Akito Nozaki, Toru Ishikawa, Tsunamasa Watanabe, Haruki Uojima, Daniel Q. Huang, Takashi Honda, Yasuhito Tanaka, Philip Vutien, Sebastián Marciano, Hiroshi Abe, Masaru Enomoto, Masanori Atsukawa, Hirokazu Takahashi, Kunihiko Tsuji, Koichi Takaguchi, Pei-Chien Tsai, Chia-Yen Dai, Jee-Fu Huang, Chung-Feng Huang, Ming-Lun Yeh, Eileen Yoon, Sung Eun Kim, Sang Bong Ahn, Gi-Ae Kim, Jang Han Jung, Soung Won Jeong, Hyunwoo Oh, Cheng-Hao Tseng, Masatoshi Ishigami, Angela Chau, Mayumi Maeda, Satoshi Yasuda, Makoto Chuma, Takanori Ito, Keigo Kawashima, Joanne Kimiko Liu, Adrian Gadano, Ritsuzo Kozuka, Norio Itokawa, Kaori Inoue, Tomonori Senoh, Jie Li, Wan-Long Chuang, Ramsey Cheung, Chao Wu, Ming-Lung Yu, Mindie H. Nguyen
Received November 27, 2024  Accepted March 14, 2025  
View: 1076   Download: 88
Letter to the Editor
Critical Considerations in Evaluating the Therapeutic Potential of HK-660S for Primary Sclerosing Cholangitis
He Yizi, He Haifeng, Liang Qi, Xie Yongzhi
Received March 1, 2025  Accepted March 13, 2025  
View: 243   Download: 19
Reply to Correspondence
SHOULD DIRECT-ACTING ANTIVIRAL BE CONSIDERED FOR ALL PATIENTS WITH HCV-RELATED HEPATOCELLULAR CARCINOMA?
Yan Ling ONG, Apichat KAEWDECH, Yu Jun WONG
Received March 5, 2025  Accepted March 10, 2025  
View: 269   Download: 11
Regulation of Hepatitis B Virus cccDNA by Metabolic Pathways
Hyeong-Jin Cho, Sung-Gyoo Park
Received March 4, 2025  Accepted March 9, 2025  
View: 384   Download: 42
Original Article
Molecular Classification of Hepatocellular Carcinoma based on Zoned Metabolic Feature and Oncogenic Signaling Pathway
Tomoko Aoki, Naoshi Nishida, Yutaka Kurebayashi, Kazuko Sakai, Naoto Fujiwara, Masakatsu Tsurusaki, Kohei Hanaoka, Masahiro Morita, Hirokazu Chishina, Masahiro Takita, Satoru Hagiwara, Hiroshi Ida, Kazuomi Ueshima, Yasunori Minami, Atsushi Takebe, Takaaki Murase, Keiko Kamei, Takuya Nakai, Ippei Matsumoto, Kazuto Nishio, Masatoshi Kudo
Received December 3, 2024  Accepted March 7, 2025  
View: 1186   Download: 142
Letter to the Editor
Letter to the Editor on “Current Burden of Steatotic Liver Disease and Fibrosis among Adults in the United States, 2017-2023”
Sisi Yang, Zhenxuan Ma
Received February 11, 2025  Accepted March 6, 2025  
View: 299   Download: 19
Letter “GULP1 as a Novel Diagnostic and Predictive Biomarker in Hepatocellular Carcinoma”
Juan Yang, Xinyi Li, Sheng Zheng
Received February 24, 2025  Accepted March 5, 2025  
View: 380   Download: 40
Correspondence
Emerging evidence supports direct-acting antiviral therapy for HCC patients beyond the early stage
Teng-Yu Lee, Pei-Chien Tsai, Shou-Wu Lee, Ming- Lung Yu
Received February 28, 2025  Accepted March 1, 2025  
View: 466   Download: 18
Research Letter
Mendelian randomization does not support the effects of G-CSF on decompensated liver disease
Li Liling, Wang Hui, Wang Hong, Huang Jinchang
Received February 27, 2025  Accepted March 1, 2025  
View: 375   Download: 35
Original Article
CD36 Promotes Iron Accumulation and Dysfunction in CD8+ T Cells via the p38-CEBPB-TfR1 Axis in Early-stage Hepatocellular Carcinoma
Yifei Qin, Fei Huo, Zhuan Feng, Jialu Hou, Yaxin Ding, Quancheng Wang, Yu Gui, Ziwei Yang, Jiali Yang, Gang Zhou, Ling Li, Jianli Jiang, Lingmin Kong, Shijie Wang, Gang Nan, Dingqiao Xu, Xiaohang Xie, Lijuan Wang, Qian He, Ruibin Yang, Peng Lin, Huijie Bian, Zhi-Nan Chen, Jiao Wu
Received November 3, 2024  Accepted March 1, 2025  
View: 996   Download: 192
Special Review
Liver Disease Trends in the Asia-Pacific Region for the Next 50 Years
Shuichiro Shiina, Javkhlan Maikhuu, Qing Deng, Terguunbileg Batsaikhan, Lariza Marie Canseco, Maki Tobari, Hitoshi Maruyama, Hiroaki Nagamatsu, Diana Alcantara-Payawal, Rino Gani, Yi-Hsiang Huang, Tawesak Tanwandee, Giovanni Galati, Yoon Jun Kim
Received January 15, 2025  Accepted February 26, 2025  
View: 566   Download: 52
Letter to the Editor
Re: "Bariatric Surgery Reduces Long-Term Mortality in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease and Cirrhosis"
Weixiong Zhu, Xuefan Zeng, Zengxi Yang, Yusheng Cheng, Wence Zhou
Received February 18, 2025  Accepted February 24, 2025  
View: 564   Download: 47
Correspondence
HCC predictors in routine practice for patients with chronic liver diseases
Tung-Hung Su, Jia-Horng Kao
Received February 18, 2025  Accepted February 22, 2025  
View: 251   Download: 5
Editorial
Direct-acting antiviral attained sustained virological response improve overall survival in patients with HCV-related hepatocellular carcinoma
Yan Ling Ong, Apichat Kaewdech, Daniel Q Huang, Yu Jun Wong
Received February 14, 2025  Accepted February 21, 2025  
View: 391   Download: 27
Letter to the Editor
Classification of microvascular invasion of hepatocellular carcinoma: different standards, common goals
Wei Chen, Yihui Rong, Tianshi Ma, Weiwei Shi, Wei Chen, Hang Jiang
Received February 11, 2025  Accepted February 14, 2025  
View: 363   Download: 39
Risk stratification for hepatocellular carcinoma in metabolic dysfunction-associated steatotic liver disease
Ho Soo Chun, Minjong Lee
Received February 2, 2025  Accepted February 7, 2025  
View: 351   Download: 18
Original Article
Radiogenomics of intrahepatic cholangiocarcinoma predicts immunochemotherapy response and identifies therapeutic target
Gu-Wei Ji, Zheng-Gang Xu, Shuo-Chen Liu, Shu-Ya Cao, Chen-Yu Jiao, Ming Lu, Biao Zhang, Yue Yang, Qing Xu, Xiao-Feng Wu, Ke Wang, Yong-Xiang Xia, Xiang-Cheng Li, Xue-Hao Wang
Received October 9, 2024  Accepted February 7, 2025  
View: 6606   Download: 250
GULP1 as a Novel Diagnostic and Predictive Biomarker in Hepatocellular Carcinoma
Hyung Seok Kim, Jung Hwan Yoon, Ji Yi Choi, Moon Gyeong Yoon, Geum Ok Baek, Minji Kang, Se Ha Jang, Won Park, Yunjin Go, Jestlin Tianthing Ng, Suk Woo Nam, Jee-Yeong Jeong, Ji Eun Han, Hyo Jung Cho, Su Bin Lim, Soon Sun Kim, Jae Youn Cheong, Jung Woo Eun
Received November 19, 2024  Accepted February 4, 2025  
View: 2262   Download: 625  Crossref: 1
Letter to the Editor
Letter to the editor on “Bariatric surgery reduces long-term mortality in patients with metabolic dysfunction-associated steatotic liver disease and cirrhosis”
Chi-Kuei Hsu, Po-Yu Huang, Chih-Cheng Lai
Received January 19, 2025  Accepted February 4, 2025  
View: 353   Download: 25
Snapshot
Interventions Targeting the Gut-Liver Axis: A Potential Treatment Strategy for MASLD
Pingping Jin, Xinyi Lu, Daozhen Chen, Yu Chen
Received December 2, 2024  Accepted February 4, 2025  
View: 504   Download: 80
Original Article
Direct-acting antiviral therapy for patients with HCV-related hepatocellular carcinoma: A nationwide cohort study
Shou-Wu Lee, Sheng-Shun Yang, Pei-Chien Tsai, Chung-Feng Huang, Chi-Yi Chen, Chao-Hung Hung, Chien-Hung Chen, Chi-Ming Tai, Pin-Nan Cheng, Hsing-Tao Kuo, Kuo-Chih Tseng, Lein-Ray Mo, Ching-Chu Lo, Yi-Hsiang Huang, Han-Chieh Lin, Pei-Lun Lee, Ming-Jong Bair, Te-Sheng Chang, Chun-Yen Lin, Szu-Jen Wang, Tsai-Yuan Hsieh, Tzeng-Hue Yang, Cheng-Yuan Peng, Chi-Chieh Yang, Lee-Won Chong, Chien-Wei Huang, Chih-Wen Lin, Cheng-Hsin Chu, Ming-Chang Tsai, Jia-Horng Kao, Chun-Jen Liu, Wan-Long Chuang, Teng-Yu Lee, Ming- Lung Yu, on behalf of TACR investigators
Received November 10, 2024  Accepted January 16, 2025  
View: 1425   Download: 107
FIB-4plus Score: A novel machine learning-based tool for screening high-risk varices in compensated cirrhosis (CHESS2004): An international multicenter study
Bingtian Dong, Ruiling He, Shenghong Ju, Yuping Chen, Ivica Grgurevic, Jianzhong Ma, Ying Guo, Huizhen Fan, Qiang Yan, Chuan Liu, Huixiong Xu, Anita Madir, Kristian Podrug, Jia Wang, Linxue Qian, Zhengzi Geng, Shanghao Liu, Tao Ren, Guo Zhang, Kun Wang, Meiqin Su, Fei Chen, Sumei Ma, Liting Zhang, Zhaowei Tong, Yonghe Zhou, Xin Li, Fanbin He, Hui Huan, Wenjuan Wang, Yunxiao Liang, Juan Tang, Fang Ai, Tingyu Wang, Liyun Zheng, Zhongwei Zhao, Jiansong Ji, Wei Liu, Jiaojiao Xu, Bo Liu, Xuemei Wang, Yao Zhang, Qiong Yan, Hui Liu, Xiaomei Chen, Shuhua Zhang, Yihua Wang, Yang Liu, Li Yin, Yanni Liu, Yanqing Huang, Li Bian, Ping An, Xin Zhang, Shaoting Zhang, Jinhua Shao, Xiangman Zhang, Wei Rao, Chaoxue Zhang, Christoph Frank Dietrich, Won Kim, Xiaolong Qi
Received October 10, 2024  Accepted February 3, 2025  
View: 1694   Download: 148
Review
Deciphering adenosine signaling in hepatocellular carcinoma: pathways, prognostic models, and therapeutic implications
Huihai Yang, Martina Mang Leng Lei, Longfei Xie, Yinuo Shou, Terence Kin Wah Lee
Received November 26, 2024  Accepted February 2, 2025  
View: 1168   Download: 116
Original Article
Baveno VI-SSM stratifies the risk of portal hypertension-related events in patients with HBV-related cirrhosis
Haiyu Wang, Weihao Liang, Ling Zhou, Jiankang Song, Biao Wen, Qiaoping Wu, Yuanjian Zhang, Xiaofeng Zhang, Haoran Ke, Yujun Tang, Fuyuan Zhou, Youfu Zhu, Weiqun Wen, Zhihua Liu, Yali Ji, Qintao Lai, Qinjun He, Wenfan Luo, Tingting Qi, Miaoxia Liu, Xiaoqin Lan, Yongpeng Chen, Ranran Xi, Junting Wan, Lin Dai, Yuan Li, Jinjun Chen
Received July 29, 2024  Accepted January 29, 2025  
View: 775   Download: 100
GDH1-dependent α-ketoglutarate promotes HBV transcription by modulating histone methylations on the cccDNA minichromosome
Sheng-Tao Cheng, Wei-Xian Chen, Hai-Jun Deng, Xin He, Hui Zhang, Ming Tan, Hai-Bo Yu, Zhen-Zhen Zhang, Ji-Hua Ren, Min-Li Yang, Da-Peng Zhang, Zhi-Hong Li, Juan Chen
Received August 21, 2024  Accepted January 28, 2025  
View: 1091   Download: 209
Review
Unveiling the Intratumor Microbiome in Liver Cancer: Current Insights and Prospective Applications
Xindi Ke, Shangze Jiang, Qiaoxin Wei, Minghao Sun, Hang Sun, Mingchang Pang, Mei Liu, Lejia Sun, Huayu Yang, Yilei Mao
Received November 19, 2024  Accepted January 20, 2025  
View: 1070   Download: 145  Crossref: 1
Original Article
Modulation of PRL-1 within placental MSCs instigates the transition between EMT and MET subsequent to hepatic fibrosis
Jae Yeon Kim, Hyeri Park, Soo Young Park, Se Ho Kim, Ja Yun Lim, Ki Seog Lee, Si Hyun Bae, Gi Jin Kim
Received September 12, 2024  Accepted January 20, 2025  
View: 4248   Download: 763
Letter to the Editor
What is new in the 2024 Chinese guidelines for fatty liver disease?
Rui-Xu Yang, Vincent Wai-Sun Wong, Jian-Gao Fan
Received December 27, 2024  Accepted January 18, 2025  
View: 441   Download: 43
Original Article
Switching to Besifovir in Patients with Chronic Hepatitis B Receiving Tenofovir Disoproxil Fumarate: A Randomized Trial
Hyung Joon Yim, Yeon Seok Seo, Ji Hoon Kim, Won Kim, Young Kul Jung, Jae Young Jang, Sae Hwan Lee, Yun Soo Kim, Chang Wook Kim, Hyoung Su Kim, Jae-Jun Shim, Eun-Young Cho, In Hee Kim, Byung Seok Lee, Jeong-Hoon Lee, Byung Seok Kim, Jeong Won Jang, Hyun Woong Lee, Jung Hyun Kwon, Moon Young Kim, Do Seon Song, Jung Gil Park, Yoon Seok Lee, Eileen L. Yoon, Han Ah Lee, Seong Hee Kang, Jin Mo Yang
Received September 19, 2024  Accepted January 16, 2025  
View: 1494   Download: 72
High SAFE scores predict hepatocellular carcinoma in viral and non-viral hepatitis and metabolic dysfunction associated steatotic liver disease
Tung-Hung Su, Sheng-Shun Yang, Mei-Hsuan Lee, Wei-Yu Kao, Shang-Chin Huang, Fen-Fang Chen, Francis SK Poon, Lung-Wen Tsai, Yi-Ting Chen, Che Lin, Weichung Wang, W Ray Kim, Jia-Horng Kao
Received September 21, 2024  Accepted January 1, 2025  
View: 1213   Download: 123
Letter to the Editor
Current Burden of MASLD, MetALD, and Hepatic Fibrosis among US Adults with Prediabetes and Diabetes, 2017-2023
Donghee Kim, Rohit Loomba, Aijaz Ahmed
Received December 20, 2024  Accepted December 29, 2024  
View: 1240   Download: 153
Original Article
Plasma lipidomics and fungal peptide-based community analysis identifies distinct signatures for early mortality in acute liver failure
Neha Sharma, Sushmita Pandey, Gaurav Tripathi, Manisha Yadav, Nupur Sharma, Babu Mathew, Abhishak Gupta, Vasundhra Bindal, Sadam H. Bhat, Yash magar, Rimsha Saif, Sanju Yadav, Amritpal Kaur, Rakhi Maiwall, Shvetank Sharma, Shiv Kumar Sarin, Jaswinder Singh Maras
Received July 12, 2024  Accepted December 10, 2024  
View: 2529   Download: 107

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X


Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: cmh_journal@ijpnc.com
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 1978
TOTAL : 2687061
Close layer